Life Science Leader Chief Editor Blog Header image Life Science Leader Chief Editor Blog Header image

Carol Lynch 1 BIO CEO 2020
BIO CEO 2020 Is No JPM — And That’s A Good Thing
Chief editor Rob Wright provides an overview of some of his experiences from recent attendance at the BIO CEO and Investor Conference in New York.  Continue Reading..
David Chang JPM 2020 refined
JPM Welcomes Life Sciences Into What Could Be The Roaring Twenties Of Discovery
Rob Wright shares his thoughts on the 38th Annual J.P. Morgan Healthcare Conference and “JPM” as we enter a decade that could be “roaring with cures.” Content specifically curated for professional development of c-level life science leaders.  Continue Reading..
GeorgeLeadershipMeeting
The Leadership Meeting – Where Leaders Go To Learn
Rob Wright provides a high-level overview of The Leadership Meeting, a pre-JPM conference with content specifically curated for professional development of c-level life science leaders.  Continue Reading..
EdTorresOrphansDec2019
Brightspot: How A Biopharma VC Makes A Difference For Orphans
Ed Torres, managing partner at Lilly Ventures, shares how he and his wife got involved in making a difference for U.S. orphans.  Continue Reading..
Tim Wright Amir Kalali and Me CNS 2019
The CNS Summit — A Caring Community Of Collaborative Solution Finders
Chief editor Rob Wright explains what differentiates the CNS Summit from other biopharmaceutical industry conferences.  Continue Reading..
Rob Wright with Fred Hassan Mar 2017
Making A Difference For Veterans: A Biopharma Bright Spot
The little known story of an immigrant couple making a $15 million difference for U.S. veterans.  Continue Reading..
reputation management_450x300
Negative Perceptions Of Biopharma — Let’s Get The Ugly On The Table
A Life Science Leader reader shares their thoughts on why the biopharmaceutical industry’s reputation is so dismal, but also proposes solutions for how to repair it.  Continue Reading..
IMG_3795
Want To Start Fixing Biopharma’s Reputation? Let’s Start By Sharing More Biopharma Brightspots
With the biopharmaceutical industry’s reputation at an all-time low, Life Science Leader’s Rob Wright looks to share little-known stories of the good being done by employees of biopharma. This first installment involves Antoine Yver, M.D., EVP and global head of R&D at Daiichi Sankyo, who helped to cofound a 501(c)3 nonprofit restaurant, The Blue Bears Special Meals.  Continue Reading..
Channel Marketing Strategies for ISVs
Have We Seen The End Of Competitive Advantage?
Thinker50 member and Columbia Business School Professor Rita Gunther McGrath, Ph.D., believes we have seen the end of sustainable competitive advantage, but has some solutions for businesses open to building strategies around transient competitive advantage.  Continue Reading..
iStock-502023041
Biopharma’s Reputation — Out Of The Frying Pan And Into The Fire
Chief Editor Rob Wright discusses the implications of the recent Gallup poll indicating pharma presently being the most poorly regarded of all industries in the eyes of Americans.  Continue Reading..

FOLLOW ROB ON TWITTER